PURE Bioscience (OTCMKTS:PURE – Get Free Report)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.06 and traded as high as $0.0667. PURE Bioscience shares last traded at $0.0667, with a volume of 10,650 shares changing hands.
PURE Bioscience Trading Up 0.4%
The firm has a market capitalization of $9.10 million, a price-to-earnings ratio of -2.33 and a beta of 0.16. The firm has a fifty day moving average price of $0.07 and a 200 day moving average price of $0.06.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last released its quarterly earnings results on Monday, June 15th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.51 million during the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
Further Reading
- Five stocks we like better than PURE Bioscience
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
